Alex Flannery and David Feola Receive Inaugural Clinical Research Catalysts Pilot Award

Alex Flannery (PharmD, PhD) and David Feola (PharmD, PhD) recently received the $50,000 University of Kentucky College of Pharmacy’s Inaugural Clinical Research Catalysts Pilot Award for their research project “Urinary Immune Cell Profiling in Sepsis-Associated Acute Kidney Injury.”

Almost 50% of all acute kidney injuries are attributed to sepsis, which is a life-threatening organ dysfunction caused by dysregulated host response to infection. Flannery and Feola’s work will forge an improved understanding of the immunobiology in various stages of kidney injury and repair due to sepsis. Having a better understanding of the contribution of the immune system to kidney injury and repair may pave the way to identify potential drug targets.

Flannery is an Assistant Professor at the University of Kentucky College of Pharmacy and received his PharmD and PhD from UKCOP. His research focuses on sepsis-associated acute kidney injury and he actively works in the Medical Intensive Care Unit at UK HealthCare. Flannery also coordinates the Evidence-Based Medicine and Clinical Reasoning courses at UKCOP.

Feola is an Associate Professor at the University of Kentucky College of Pharmacy and received his PharmD and PhD from UKCOP. His research focuses on immunology and he teaches infectious disease pharmacotherapy in the Integrated Drugs and Diseases course sequence. Feola is also the Director of Graduate Studies for the College of Pharmacy.